[1] State Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I(中华人民共和国药典,一部)[M]. 2020 ed. Beijing: China Medical Science and Technology Press, 2010: 164-165. [2] LIN L, NI B, LIN H, et al.Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb: a review[J]. J Ethnopharmacol, 2015, 15(159): 158-183. [3] HINSHAW LB. Sepsis/septic shock: participation of the microcir-culation: an abbreviated review[J]. Crit Care Med, 1996, 24, 9(6): 1072-1078. [4] PANIS B, WONG DR, H OOYMANS PM, et al. Recurrent toxic hepatitis in a caucasian girl related to the use of Shou Wu Pian, a Chinese herb alpreparat ion[J].J Pediatr Gastroenterol Nutr, 2005,41: 256-258. [5] KYOUNG AJ, HYUN JM, SEUNG SY, et al.Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of polygonum multiflorum Thunb[J]. Gut and Liver, 2011, 5(4): 493-499. [6] MA NH, CHEN Y, XU CSH, et al.Research progress of liver injury induced by Polygoni Mulitiflori Radix[J]. China Journal of Chinese Material Medica(中国中药杂志),2020, 45(15): 3594-3602. [7] China Food and Drug Administration. Drug Safety Alert.(2014-07-16)[2021-06-08]. https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20140716151101983.html. [8] Center for Drug Reevaluation, NMPA. British MHRA warns polygonum multiflorum of adverse reactions to liver damage[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2006, 3(5): 313-314. [9] GARZEL B, YANG H, ZHANG L, et al.The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity[J]. Drug Metab Dispos, 2014, 42(3) : 318-322. [10] GAO X, FU T, WANG C, et al.Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury[J]. Biochemical Pharmacology, 2017(146): 127-138. [11] LIU WY, SUN JG, CAO WL, et al.Advances in farnesoid X receptor antagonists and their pharmacological activities[J]. Chin J Clin Pharmacol Ther(中国临床药理学与治疗学), 2020, 25(70):764-774. [12] LIN L, NI B, LIN H, et al.Traditional usages, botany, phytoc-hemistry, pharmacology and toxicology of Polygonum multiflorum Thunb: a review[J]. J Ethnopharmacol, 2015, 15(159): 158-183. [13] WANG Q, LI Y, WANG YD, et al.Investigation of potential hepatotoxic components in Polygonum Multiflorum based on molecular docking and rat liver microsome inhibition test[J]. Drug Evaluation Research(药物评价研究), 2019, 42(40): 635-640. [14] YAN YJ, DAN M, WANG Q, et al.Hepatotoxicity evaluation of Polygonum Multiflorum based on 2D and 3D hepatocyte models in vitro[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(7): 385-392. [15] DAN M, LIU D, HUANG SJ, et al.Study the hepatotoxicity of monoanthranone with emodin-type using in vitro 3D liver model[J]. Chinese Journal of New Drugs(中国新药杂志), 2019, 28(11): 1312-1317. [16] ZHANG GQ, CHEN L, WEN YJ, et al.Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury[J]. Toxicology and Applied Pharmacology, 2020, 402, 115134. [17] YANG M, LIU T, FENG WH, et al.Exploration research on hepatotoxic constituents from Polygonum multiflorum root[J]. China Journal of Chinese Material Medica(中国中药杂志), 2016, 41(7): 1289-1296. [18] WEI PF, HU XQ, MIAO YX, et al.Study on the correlation between different components of shouwu inducing hepatocyte apoptosis and tumor necrosis factor α[J]. Journal of Sichuan Traditional Chinese Medicine(四川中医), 2009, 27(10): 47-48. |